newsfilter
← Latest News
GlobeNewswire·

Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products

Levitee Labs acquiring 51% interest in new R&D compounding pharmacy in Calgary, Alberta, Canada New pharmacy to focus on production of intranasal ketamine and sublingual preparations, topical and transdermal formulations, capsules and other Levitee-bra